Target intelligence / Profile preview

Host cell surface receptors involved in Dengue virus entry (DENV entry receptors)

Target
DENV entry receptors
Molecular classification
C-type lectin, Receptor tyrosine kinase, Chaperone, Proteoglycan, Phosphatidylserine receptor, Other
01

Overview

Dengue virus (DENV) entry into host cells is a complex, multi-step process involving several cell surface molecules that act as attachment factors or entry receptors. Initial tethering is frequently mediated by heparan sulfate proteoglycans (HSPGs) and C-type lectins, most notably DC-SIGN (CD209) on dendritic cells and L-SIGN (CD209L) on endothelial cells, which bind to the N-linked glycans of the DENV envelope (E) protein [PMID: 12502850, 25157315]. Subsequent to attachment, the virus utilizes receptors such as AXL, a member of the TAM family of receptor tyrosine kinases, and TIM-1 to facilitate internalization through a process known as apoptotic mimicry [PMID: 23472551]. Other proteins, including the chaperone GRP78 and the signaling receptor CLEC5A, are also involved in the entry or the induction of the pro-inflammatory response following infection [PMID: 18496526]. Because DENV can infect a wide range of cell types using different combinations of these receptors, they are considered significant therapeutic targets for the development of entry inhibitors. However, the redundancy of these entry pathways and the physiological importance of the host proteins present challenges for achieving high efficacy without significant toxicity.

Other names
Dengue virus entry receptorsDENV attachment factorsCD209 (DC-SIGN)CD209L (L-SIGN)AXL receptor tyrosine kinaseCLEC5ATIM-1 (HAVCR1)GRP78 (HSPA5)Heparan sulfate proteoglycans (HSPG)Mannose receptor (CD206)
02

Mechanism of action

Inhibition of viral attachment to host cells, blockade of receptor-mediated endocytosis, and interference with phosphatidylserine-mediated apoptotic mimicry to prevent viral internalization.

03

Biological functions

Viral entryCell signalingImmune responseEndocytosisApoptotic mimicryProtein foldingCell adhesion
04

Disease associations

Infection
05

Safety considerations

Interference with host immune surveillance and antigen presentationDisruption of homeostatic efferocytosis (clearance of apoptotic cells)Potential for antibody-dependent enhancement (ADE) if neutralization is incompleteOff-target effects of kinase inhibitorsViral escape through alternative receptor usage
06

Interacting drugs

Heparin

5 more in the full profile.

07

Biomarkers

Dengue virus NS1 antigenDengue virus RNA (RT-PCR)Pro-inflammatory cytokine levels (TNF-alpha, IL-6)Soluble CD209 (potential)

Beyond the preview

Go deeper on Host cell surface receptors involved in Dengue virus entry (DENV entry receptors).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host cell surface receptors involved in Dengue virus entry (DENV entry receptors).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call